Analyst Ratings for Heron Therapeutics (HRTX) [Buys]
HRTX Rating Summary
HRTX Price Target Summary
- Highest: $5.00 (Needham)
- Lowest: $2.50 (TD Cowen)
- Average: $3.75
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
=
Avg. $ Target:
$3.75 (+44.8%)
* Over Last 12-Mos
Rating Score: 10 / 10
Percentile Rank: 95%
Rating Score: 10 / 10
Percentile Rank: 95%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 5/27/2020 | Guggenheim | Dana Flanders | New Coverage | Buy (N/A) |
24.00 (N/A) |
18.24 (2.59) |
-85.8% | Details |
| 9/14/2018 | Stifel » Updated 5/13/2021 |
Derek Archilia | New Coverage | Buy (N/A) |
27.00 (N/A) |
34.95 (2.59) |
-92.59% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
